Physician profile
Michael Tu
NPI 1174960934
$724.06
in general payments reported to CMS, 2019-2025
9 companies · $143 in 2025
The $143 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $191 · 2020: $123 · 2023: $99.63 · 2024: $167 · 2025: $143.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $410.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $409.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $436.77 | 2019-2025 | Jardiance |
| Amgen INC. | $59.40 | 2020-2023 | Evenity, Prolia |
| Novo Nordisk INC | $55.52 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $46.21 | 2019-2020 | |
| Lilly USA, LLC | $36.38 | 2019-2025 | Jardiance |
| Sanofi-Aventis U.S. LLC | $29.34 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $23.82 | 2019 | |
| Xeris Pharmaceuticals, INC. | $18.69 | 2025 | Gvoke Hypopen |
| Phadia US INC. | $17.93 | 2024 | Immunocap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Tu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.